Publications (11) ELIZABETA DE LOS ÁNGELES ROJAS RICARDO publications

filter_list

2022

  1. Expression of p53 protein isoforms predicts survival in patients with multiple myeloma

    American Journal of Hematology, Vol. 97, Núm. 6, pp. 700-710

  2. Genomics of Plasma Cell Leukemia

    Cancers, Vol. 14, Núm. 6

  3. RNA sequencing identifies novel regulated IRE1-dependent decay targets that affect multiple myeloma survival and proliferation

    Experimental Hematology and Oncology, Vol. 11, Núm. 1

  4. TCL-318 Evaluation of the Antitumor Activity of Amiloride in Peripheral T-Cell Lymphomas Using In-Vitro Models

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S399

  5. Transcriptional signature of TP53 biallelic inactivation identifies a group of multiple myeloma patients without this genetic condition but with dismal outcome

    British Journal of Haematology, Vol. 199, Núm. 3, pp. 344-354

2020

  1. Effect of graphene family materials on multiple myeloma and non-Hodgkin's lymphoma cell lines

    Materials, Vol. 13, Núm. 15, pp. 1-21

  2. Quantitative expression of Ikaros, IRF4, and PSMD10 proteins predicts survival in VRD-treated patients with multiple myeloma

    Blood Advances, Vol. 4, Núm. 23, pp. 6023-6033

  3. Systematic comparison and assessment of RNA-seq procedures for gene expression quantitative analysis

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Factors regulating microRNA expression and function in multiple myeloma

    Non-coding RNA, Vol. 5, Núm. 1

  2. Transcriptome analysis reveals significant differences between primary plasma cell leukemia and multiple myeloma even when sharing a similar genetic background

    Blood Cancer Journal, Vol. 9, Núm. 12

2018

  1. A novel nano-immunoassay method for quantification of proteins from CD138-purified myeloma cells: Biological and clinical utility

    Haematologica, Vol. 103, Núm. 5, pp. 880-889